← SynDRA
PBF-509
SynDRA canonical compound SYN0038402 — structure-anchored drug synonym record
| Clinical phase | Phase 1/Phase 2 |
|---|
| Primary target(s) | ADORA2A |
|---|
| Mechanism of action | adenosine receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- ADORA2A ANTAGONIST
- Adenosine A2a receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Cross-references
Synonyms
- Taminadenant
- PF-509
- 4-Pyrimidinamine, 5-bromo-2,6-di-1H-pyrazol-1-yl-
- taminadenantum
- RefChem:1099388
- A2AR Antagonist PBF-509
- 5-bromo-2,6-di(1H-pyrazol-1-yl)pyrimidin-4-amine
- C10H8BrN7
- 5-bromo-2,6-di(pyrazol-1-yl)pyrimidin-4-amine
- Taminadenant [INN]
- MFCD30489281
- PBF509
- 5-bromo-2,6-bis(1H-pyrazol-1-yl)pyrimidin-4-amine
- TAMINADENANT [WHO-DD]
- UNII-84I5UEP321
- 5-Bromo-2,6-di-(1h-pyrazol-1-yl)pyrimidine-4-amine
- orb1307703
- SCHEMBL2546228
- SCHEMBL29421140
- GTPL10193
- ATFXVNUWQOXRRU-UHFFFAOYSA-N
- BDBM128295
- EX-A9886
- NSC817041
- AKOS030527812
- NSC-817041
- DS-19509
- DW-71177
- DB-206736
- HY-109139
- CS-0086930
- C72343
- T16980
- US8796284, 1
- F541628
Look up PBF-509 in the interactive SynDRA portal →